Literature DB >> 11313769

Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.

L Cuisset1, J P Drenth, A Simon, M F Vincent, S van der Velde Visser, J W van der Meer, G Grateau, M Delpech.   

Abstract

Hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) is an autosomal recessive inflammatory disorder characterised by recurrent episode of fever associated with lymphadenopathy, abdominal distress, joint involvement and skin lesions. We recently demonstrated that mutations in the mevalonate kinase gene (MVK) are associated with HIDS. Direct DNA sequencing was done to screen the entire coding region of MVK in 25 unrelated patients with HIDS. Mutations were detected in the coding region of the gene including 11 missense mutations, one deletion, the absence of expression of one allele, as well as three novel polymorphisms. Seven of these mutations are novel. The large majority of the patients were compound heterozygotes for two mutations. Of these, V377I (G-->A) is the most common mutation occurring in 20 unrelated patients and was found to be associated with I268T in six patients. Mutations were associated with a decrease of mevalonate kinase (MK) (ATP:mevalonate 5-phosphotransferase, EC 2.7.I.36) enzymatic activity but not as profound as in mevalonic aciduria, a syndrome also caused by a deficient activity of MK. In HIDS the mutations are located all along the protein which is different from mevalonic aciduria where MK mutations are mainly clustered to a same region of the protein. On the basis of this study, we propose that the diagnostic screen of MVK in HIDS should be first directed on V377I and I268T mutations. Three patients are also described to illustrate the genotypic and phenotypic overlap with mevalonic aciduria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313769     DOI: 10.1038/sj.ejhg.5200614

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  48 in total

Review 1.  Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.

Authors:  Svetlana Kostjukovits; Liisa Kalliokoski; Kaisu Antila; Matti Korppi
Journal:  Eur J Pediatr       Date:  2015-02-27       Impact factor: 3.183

2.  Crescentic glomerulonephritis is part of hyperimmunoglobulinemia D syndrome.

Authors:  Mathilde Cailliez; Florentine Garaix; Caroline Rousset-Rouvière; Daniele Bruno; Laurent Daniel; Brigitte Chabrol; Jacques Sarles; Michel Tsimaratos
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

Review 3.  Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.

Authors:  Gina A Montealegre Sanchez; Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Rheum Dis Clin North Am       Date:  2013-09-21       Impact factor: 2.670

4.  Intermittent neutropenia as an early feature of mild mevalonate kinase deficiency.

Authors:  Nima Parvaneh; Vahid Ziaee; Mohammad-Hassan Moradinejad; Isabelle Touitou
Journal:  J Clin Immunol       Date:  2013-11-01       Impact factor: 8.317

Review 5.  Genetics of monogenic autoinflammatory diseases: past successes, future challenges.

Authors:  Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Rev Rheumatol       Date:  2011-07-05       Impact factor: 20.543

Review 6.  The emerging role of interleukin-1β in autoinflammatory diseases.

Authors:  Thirusha Lane; Helen J Lachmann
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 7.  Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.

Authors:  Kyawt Win Shwin; Chyi-Chia Richard Lee; Raphaela Goldbach-Mansky
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

8.  [Molecular diagnostics of hereditary fever syndromes. Familial Mediterranean fever (FMF), hyperimmunoglobulin D syndrome (HIDS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS: FCAS, MWS, NOMID/CINCA)].

Authors:  C Timmann; R Horstmann
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 9.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

10.  Developments in the scientific and clinical understanding of autoinflammatory disorders.

Authors:  Helen J Lachmann; Philip N Hawkins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.